Your browser doesn't support javascript.
loading
Effect of sarcopenia on short-term outcomes of gastric endoscopic submucosal dissection.
Tanaka, Hironori; Iwatsubo, Taro; Sasaki, Shun; Nakajima, Noriyuki; Mori, Yosuke; Hakoda, Akitoshi; Sugawara, Noriaki; Ota, Kazuhiro; Nishikawa, Hiroki.
Afiliação
  • Tanaka H; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Iwatsubo T; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan. tarou.iwatsubo@ompu.ac.jp.
  • Sasaki S; Endoscopy Center, Osaka Medical and Pharmaceutical University Hospital, 2-7, Daigakumachi Takatsuki, Osaka, 569-8686, Japan. tarou.iwatsubo@ompu.ac.jp.
  • Nakajima N; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Mori Y; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Hakoda A; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Sugawara N; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Ota K; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Nishikawa H; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Surg Endosc ; 2024 Jun 12.
Article em En | MEDLINE | ID: mdl-38864884
ABSTRACT

BACKGROUND:

Sarcopenia has been reported to be associated with short-term outcomes after gastric endoscopic submucosal dissection (ESD). The "strength, assistance with walking, rising from a chair, climbing stairs, and falls" (SARC-F) questionnaire has been widely used as a screening tool for sarcopenia; however, SARC-F combined with body mass index and age (SARC-F+EBM) has recently been reported to be more useful than SARC-F alone. This study aimed to investigate the association between sarcopenia, measured using SARC-F+EBM, and short-term outcomes after gastric ESD.

METHODS:

Patients who underwent gastric ESD at our institution between May 2020 and June 2023 were included, and their medical records were reviewed retrospectively. A SARC-F+EBM score ≥ 12 indicated sarcopenia. We evaluated the incidence of adverse events and the length of hospital stay in the sarcopenia and non-sarcopenia groups.

RESULTS:

Overall, 263 patients (64 and 199 in the sarcopenia and non-sarcopenia groups, respectively) were investigated. The incidence of adverse events with a Common Terminology Criteria for Adverse Events grade ≥ 3 was not significantly different between the sarcopenia and non-sarcopenia groups (6.2% vs. 8.5%, p = 0.791). The proportion of patients with an extended hospital stay (≥ 10 days) was significantly higher in the sarcopenia group than that in the non-sarcopenia group (12.5% [8/64] vs. 3.5% [7/199], p = 0.012). Multivariate analysis showed that sarcopenia and lesions that present technical difficulty in ESD were independent risk factors for extended hospital stays (≥ 10 days). Of the eight cases having extended hospital stays in the sarcopenia group, four were due to the management after gastric ESD, three were due to family circumstances, and one was due to decreased activities of daily living.

CONCLUSIONS:

Sarcopenia is not a predictor of adverse events associated with gastric ESD. However, patients with sarcopenia may be hospitalized for longer owing to non-ESD-related factors.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article